Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark.
Eur J Immunol. 2010 May;40(5):1342-54. doi: 10.1002/eji.200939830.
Most novel vaccines against infectious diseases are based on recombinant Ag; however, only few studies have compared Ag-specific immune responses induced by natural infection with that induced by the same Ag in a recombinant form. Here, we studied the epitope recognition pattern of the tuberculosis vaccine Ag, TB10.4, in a recombinant form, or when expressed by the pathogen Mycobacterium tuberculosis (M.tb), or by the current anti-tuberculosis vaccine, Mycobacterium bovis BCG. We showed that BCG and M.tb induced a similar CD4+ T-cell specific TB10.4 epitope-pattern, which differed completely from that induced by recombinant TB10.4. This difference was not due to post-translational modifications of TB10.4 or because TB10.4 is secreted from BCG and M.tb as a complex with Rv0287. In addition, BCG and TB10.4/CAF01 were both taken up by DC and macrophages in vivo, and in vitro uptake experiments revealed that both TB10.4 and BCG were transported to Lamp+-compartments. BCG and TB10.4 however, were directed to different types of Lamp+-compartments in the same APC, which may lead to different epitope recognition patterns. In conclusion, we show that different vectors can induce completely different recognition of the same protein.
大多数针对传染病的新型疫苗都是基于重组抗原(Ag)的;然而,只有少数研究比较了天然感染和重组形式下相同抗原诱导的 Ag 特异性免疫反应。在这里,我们研究了结核疫苗抗原 TB10.4 的表位识别模式,TB10.4 以重组形式、病原体结核分枝杆菌(M.tb)或当前的抗结核疫苗牛分枝杆菌卡介苗(BCG)表达。我们表明,BCG 和 M.tb 诱导了与重组 TB10.4 完全不同的相似的 CD4+T 细胞特异性 TB10.4 表位模式。这种差异不是由于 TB10.4 的翻译后修饰引起的,也不是因为 TB10.4 作为与 Rv0287 形成的复合物从 BCG 和 M.tb 中分泌出来的。此外,BCG 和 TB10.4/CAF01 都在体内被 DC 和巨噬细胞摄取,体外摄取实验表明,TB10.4 和 BCG 都被转运到 Lamp+-区室。然而,BCG 和 TB10.4 被递送到同一 APC 中的不同类型的 Lamp+-区室,这可能导致不同的表位识别模式。总之,我们表明,不同的载体可以诱导对同一蛋白的完全不同的识别。